Friday, March 29, 2024
Advertisement

Mediclinic shares tumble as it warns of drop in earnings

Shares in international private healthcare group Mediclinic International plummeted this morning (17 October) after the London-listed company flagged an 8% drop in EBITDA to...

Challenges persist despite growing care revenues at Bupa

Rising fee rates and occupancy across care services helped deliver revenue growth at Bupa, as the business continues to navigate the impacts of Covid-19....

Apposite raises new £200m healthcare fund

Specialist private equity investor Apposite Capital has raised £200m for Apposite Healthcare III and associated vehicles. The the main fund closed in July 2022 above its original...
Nigeria: Noor Dubai Foundation launches eye care programme in Katsina

Nordic Capital acquires Ober Scharrer Group

Nordic Capital Fund IX has acquired OberScharrer Group (OSG), a German ophthalmology provider, from Palamon Capital Partners. The value of the deal has not been...
Fertility experts urge IVF clinics to share success rates

NMC looks to enter UK fertility market

One of the Gulf’s leading hospital providers, London-listed NMC Health, has said it wants to expand its fertility business in the UK. In his first...

Sky-high thinking: Ageing in Asia

How to cater for an ageing population is big business across Asia. Alistair Kleebauer looks at some of the products and services that are...

Spex Capital launches €100m fund for early stage healthtech ventures

Digital health and med-tech investment firm Spex Capital has launched a new fund with a target size of €100m. The Spex Venture HealthTech Fund is a closed-end...

Sweden: Eir Ventures I life sciences VC fund closes at €122.3m

Eir Ventures, a Nordic Life Science Venture Capital manager, has closed Eir Ventures I at €122.3m (US$137.8m) . The fund is the firm’s first...

Spain: Ysios Capital targets 15 investments from close of €216m third fund

Spain-based biotech venture capital firm, Ysios Capital, has closed its third fund, Ysios BioFund 3 (YBF 3) at €216m (US$264m). Its largest fund to date,...

IVIRMA takes 10% share of UK IVF market with acquisition of CREATE Fertility

International reproductive medicine giant IVIRMA Global has strengthened its UK footprint with the acquisition of former family-owned IVF businesses CREATE Fertility and abc IVF. Financial...